IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.261
EU - Europa 32.426
AS - Asia 14.329
SA - Sud America 2.796
AF - Africa 233
Continente sconosciuto - Info sul continente non disponibili 151
OC - Oceania 39
Totale 91.235
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.944
RU - Federazione Russa 9.236
GB - Regno Unito 7.658
SG - Singapore 6.750
IT - Italia 4.685
CN - Cina 3.121
DE - Germania 2.693
UA - Ucraina 2.548
BR - Brasile 2.442
CA - Canada 2.018
HK - Hong Kong 1.747
DK - Danimarca 1.575
VN - Vietnam 1.268
SE - Svezia 867
IE - Irlanda 719
FR - Francia 632
FI - Finlandia 622
PL - Polonia 361
IN - India 271
NL - Olanda 248
MX - Messico 207
TR - Turchia 190
AT - Austria 161
BD - Bangladesh 153
EU - Europa 149
PK - Pakistan 119
AR - Argentina 104
ES - Italia 104
IQ - Iraq 102
ID - Indonesia 91
JP - Giappone 79
ZA - Sudafrica 77
LT - Lituania 60
UZ - Uzbekistan 58
EC - Ecuador 55
KR - Corea 54
IR - Iran 52
VE - Venezuela 48
CO - Colombia 47
AE - Emirati Arabi Uniti 46
BE - Belgio 44
SK - Slovacchia (Repubblica Slovacca) 43
SA - Arabia Saudita 42
MA - Marocco 39
CH - Svizzera 31
PE - Perù 28
RO - Romania 28
CZ - Repubblica Ceca 26
AU - Australia 24
KE - Kenya 23
UY - Uruguay 21
CL - Cile 20
JO - Giordania 20
IL - Israele 18
JM - Giamaica 18
PT - Portogallo 18
AZ - Azerbaigian 17
DZ - Algeria 17
EG - Egitto 17
TN - Tunisia 17
AM - Armenia 16
BO - Bolivia 15
PH - Filippine 15
TT - Trinidad e Tobago 15
NZ - Nuova Zelanda 13
PY - Paraguay 13
TW - Taiwan 12
CR - Costa Rica 11
NP - Nepal 11
HN - Honduras 10
KG - Kirghizistan 9
MY - Malesia 9
OM - Oman 9
BB - Barbados 8
MC - Monaco 8
TH - Thailandia 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GE - Georgia 7
HU - Ungheria 7
NI - Nicaragua 7
PS - Palestinian Territory 7
GT - Guatemala 6
KZ - Kazakistan 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
AO - Angola 5
BH - Bahrain 5
GR - Grecia 5
LB - Libano 5
MG - Madagascar 5
MT - Malta 5
NG - Nigeria 5
NO - Norvegia 5
BY - Bielorussia 4
EE - Estonia 4
HR - Croazia 4
LV - Lettonia 4
Totale 91.188
Salva come PNG Salva come JPEG
Città #
Southend 5.518
Singapore 3.892
Woodbridge 2.866
Chandler 2.554
Ann Arbor 2.547
Beijing 2.338
Houston 2.208
Fairfield 1.913
San Mateo 1.857
Chicago 1.642
Falls Church 1.553
Hong Kong 1.521
Dearborn 1.327
Ashburn 1.302
Seattle 1.273
Jacksonville 1.195
Cambridge 1.143
Wilmington 1.143
Los Angeles 967
Moscow 958
Ottawa 943
Salt Lake City 718
Boardman 707
Dublin 703
Stevenage 685
Portsmouth 682
The Dalles 663
Dong Ket 641
Pisa 593
Lawrence 525
Beauharnois 444
Tampa 407
Montréal 406
Munich 397
Buffalo 385
Milan 346
Santa Clara 343
Warsaw 338
Brooklyn 323
Elk Grove Village 321
Rome 287
London 237
São Paulo 222
San Diego 213
New York 190
Dallas 189
Florence 184
Frankfurt am Main 169
Redwood City 160
Old Bridge 158
Nuremberg 157
Sterling 151
Lancaster 145
Helsinki 125
Central District 114
Miami 109
Istanbul 106
Turku 102
Dulles 95
Lappeenranta 94
San Francisco 92
Fremont 91
Rio de Janeiro 87
Norwalk 85
Boston 83
Washington 80
Bologna 79
Kansas City 79
Phoenix 78
Guangzhou 76
Belo Horizonte 68
Lucca 67
Mexico City 66
Toronto 65
Montreal 64
Detroit 63
Atlanta 60
Genoa 59
Livorno 59
Stockholm 58
Tokyo 58
Vienna 58
Amsterdam 57
Shanghai 57
Chennai 55
Tashkent 54
Brasília 53
Shenzhen 53
Assago 50
Hanoi 49
Johannesburg 49
Turin 48
Naples 46
Pittsburgh 44
Bratislava 43
Düsseldorf 43
Curitiba 41
Ho Chi Minh City 41
Lauterbourg 41
Paris 41
Totale 55.934
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.726
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.500
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.407
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.195
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 758
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 479
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 343
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 311
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 284
La neuropatia diabetica 274
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 264
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 260
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 256
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 247
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 232
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 227
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 225
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 222
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 221
Treating chemoreflex in heart failure: modulation or demolition? 218
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 217
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 217
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 217
Building medical knowledge from real world registries: The case of heart failure 217
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 215
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 214
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 214
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 212
Cartella clinica automatizzata per il reparto di cardiologia 211
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 211
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 209
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 208
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 207
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 207
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 206
An Open System for Managing Long Term ECG Recordings 205
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 205
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 205
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 204
Development of an Electronic Medical Record for Patient Care in Cardiology 203
Medical record System for Cardiology and Cardiac Surgery 201
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 201
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 201
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 201
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 200
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 200
Nuovi strumenti di management per la gestione integrata dei percorsi assistenziali dei pazienti cronici 200
B-type natriuretic peptide secretion following scuba diving 199
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 199
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 197
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 196
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 195
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 195
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 195
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 194
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 194
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 194
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 193
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 192
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 192
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 190
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 190
Effects of smoking in patients treated with cardiac resynchronization therapy 190
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 190
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 188
Development of an Electronic Medical Record System for the Department of Cardiology 187
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 187
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 186
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 186
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 186
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 185
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 185
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 185
Prediction of the chemoreflex gain by common clinical variables in heart failure 185
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 184
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 184
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 184
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 184
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 184
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 184
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 183
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 182
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 182
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 182
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 182
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 182
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 182
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 182
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 181
Cardiac production of C-type natriuretic peptide in heart failure. 181
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 181
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 181
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 181
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 180
Update sui biomarcatori nello scompenso cardiaco. 180
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 180
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 180
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 179
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 178
C-type natriuretic peptide and heart failure 178
Totale 26.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 592.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 592.742
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.832 0 1.246 530 894 633 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/20265.161 4.297 864 0 0 0 0 0 0 0 0 0 0
Totale 92.127